Coherus Oncology Inc (CHRS)

Financing Cash Flow

$53.73M

Quarterly · Period ending: · USD

CHRS logo

CHRS Financing Cash Flow

Latest reported$53.73M
CHRS Quarterly Cash from Financing ($0.00 → $53.73M)
High-resolution chart · PNG

CHRS financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
53,734,000
53,590,000
8,081,000
2,000
-281,524,000
-264,000
231,000
-167,000
-187,925,000
887,000
366,000
11,105,000
54,325,000
3,804,000
6,593,000
48,867,000
721,000
-1,855,000
1,487,000
1,101,000
46,852,000
2,439,000
5,513,000
4,088,000
210,422,000
3,923,000
1,200,000
3,683,000
3,010,000
81,477,000
2,593,000
1,058,000
99,892,000
1,878,000
6,892,000
75,082,000
-184,000
124,997,000
55,999,000
1,254,000
69,083,000
99,843,000
330,000
10,463,000
112,625,000
-729,000
83,766,000
-1,784,000
53,966,000
8,000
0
9,956,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.